Summary of developments in oesophageal and gastric cancers
26 Jul 2016
Summary of developments in oesophageal and gastric cancers
Updates in prostate and bladder cancer therapy
Lung cancer immunotherapy
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Regulation of T cells in tissues and tumours
Cured AML patients generate anti-tumour antibodies that kill AML blasts
Combination trial designs: efficient, effective and tolerable regimens
Patient perspectives in precision medicine: 'No innovation about us without us'
WIN 2016 highlights: Changing the understanding of cancer
Editor's Choice for June 2016
Editor's ASCO 2016 Roundup
Latest in precision cancer medicine